• 대한약리학회지
• /
• 제30권1호
• /
• pp.137-143
• /
• 1994

본 연구는 7종의 비스테로이드성 항염증제가 FMLP에 의한 사람 중성구의 이동에 미치는 영향을 약물의 농도별로 관찰하고자, Hypaque-Ficoll step gradient centrifugation방법에 의하여 중성구를 분리하고, 48-well micro chemotaxis assembly를 이용하여 chemotactic assay를 시행하여 다음과 같은 결과를 얻었다. Oxyphenbutazone, phenylbutazone, zomepirac, ibuprofen은 약물의 치료 농도하에서 중성구의 이동에 대한 강력한 억제작용을 나타내었으며, indomethacin은 중성구의 이동을 오히려 증가시키는 작용을 나타내었다. 이 약제들은 모두 100uM미만의 약물 농도에서 각각 IC50를 나타내었으며, oxyphenbutazone, phenylbutazone은 10uM에서 최대 억제효과를 나타내었고, zomepirac, ibuprofen은 각각 0.luM과 100uM에서 가장 강한 억제 작용을 나타내었다. 또한 상기 약제를 FMLP와 함께 하단 구획에 첨가하였을 때에는 세포와 함께 상단구획에 첨가하였을 때와는 상이하게 세포의 이동에 전혀 영향을 미치지 못하였다. 이러한 결과는 이 약제가 FMLP와의 분자적 상호 작용을 통하여 FMLP의 작용을 저하시키는 것보다는 세포에 직접적인 영향을 미침으로서 세포의 이동을 억제하였음을 나타내어 준다. 이상의 연구 결과에서, oxyphenbutazone등의 약제가 100uM미만의 저농도에서 FMLP에 의한 중성구의 이동을 강력하게 억제하는 작용이 있음을 보고, 이 작용은 지금까지 비스테로이드성 함염증제의 작용 기전으로 말려진 cyclooxygenage 억제 작용과는 별개의 기전으로 사료되므로, 이를 상기 약제가 세포 수준에서 나타내는 제 2의 약리 기전으로 제시한다.denosine의 효과를 길항함을 볼 수 있었으나 $K{^+}$-통로 차단제인 glibenclamide는 adenosine의 효과에 영향을 미치지 못하였다. 8-Bromo-cAMP (100과 $300{\mu}M$) 그 자체로는 ACh 유리에 별다른 영향을 미치치 못하였으나 $300\;{\mu}M$ 8-bromo-cAMP 전처리에 의하여 $30\;{\mu}M\;adenosine$의 효과가 억제됨을 볼 수 있었다. 이상의 실험결과로 흰쥐 해마에서 $A_1-adenosine$ 수용체를 통한 adenosine의 ACh유리 감소는 G-단백에 의존적이며, 이러한 효과에 nifedipine에 예민한 $Ca^{++}$-통로와 adenylate cyclase계가 일부 관여함은 확실하나 proteinkinase C 및 glibenclamide에 예민한 $K{^+}$통로는 관여하지 않는 것으로 사료된다.(新稱), Phellinus pomaceus), 회주름구멍버섯(신칭(新稱), Antrodia crassa), 층주름구멍버섯(신칭(新稱), Antrodia serialis), 흰그물구멍버섯(신칭(新稱), Ceriporia reticulata), 겹친손등버섯(신칭(新稱), Oligoporus balsameus), 점박이손등버섯(신칭(新稱), Oligoporus guttulatus), 무른흰살버섯(신칭(新稱), Oxyporus cuneatus), 각목버섯(신칭(新稱), Rigidoporus microporus), 및 주름옷솔버섯(신칭(新稱), Trichaptum laricinum)으로서 우리말 이름과 영문 기재(記載)와 함께 우리나라의 균류목록(菌類目錄)에 새로이 추가되었다. 이였으며, White+NAA

• 대한미생물학회지
• /
• 제21권3호
• /
• pp.311-329
• /
• 1986

The experimental exposure of animals to sources of ultraviolet radiation (UVR) which emit their energy primarily in the UVB region (280-320nm) is known to result in a number of well-described changes in the recipient's immune competence. Two such changes include a depressed capacity to effectively respond immunologically to transplants of syngeneic UVR tumors and a markedly reduced responsiveness to known inducers of delayedtype (DTH) and contact hypersensitivity (CH) reactions. The results of experiments that were designed to elucidate the mechanisms responsible for UVR-induced immunomodulation have implicated: 1) an altered pattern of lymphocyte recirculation, 2) suppressor T cells(Ts), 3) deviations in systemic antigen presenting cell (APC) potential. 4) changes in the production of interleukin-1-like molecules, and 5) the functional inactivation of epidermal Langerhans cells in this process. The exposure of skin to UVR, therefore, causes a number of both local and systemic alterations to the normal host immune system. In spite of this seeming complexity and diversity of responses, our recent studies have established that each of the UVR-mediated changes is probably of equal importance to creating the UVR-induced immunocompromised state. Normal animals were exposed to low dose UVR radiation on their dorsal surfaces under conditions where a $3.0\;cm^2$ area of skin was physically protected from the light energy. Contact sensitization of these animals with DNFB, to either the irradiated or protected back skin, resulted in markedly reduced CH responses. This was observed in spite of a normal responsiveness following the skin sensitization to ventral surfaces of the UVR-exposed animals. Systemic treatment of the low dose UVR recipients with the drug indomethacin (1-3 micrograms/day) during the UVR exposures resulted in a complete reversal of the depressions observed following DNFB sensitization to "protected" dorsal skin while the altered responsiveness found in the group exposed to the skin reactive chemical through directly UVR-exposed sites was maintained. These studies implicate the importance of EC as effective APC in the skin and also suggest that some of the systemic influences caused by UVR exposure involve the production of prostaglandins. This concept was further supported by finding that indomethacin treatment was also capable of totally reversing the systemic depressions in CH responsiveness caused by high dose UVR exposure (30K joules/$m^2$) of mice. Attempts to analyze the cellular mechanisms responsible established that the spleens of all animals which demonstrated altered CH responses, regardless of whether sensitization was through a normal or an irradiated skin site, contained suppressor cells. Interestingly, we also found normal levels of T effector cells in the peripheral lymph nodes of the UVR-exposed mice that were contact sensitized through normal skin. No effector cells were found when skin sensitization took place through irradiated skin sites. In spite of such an apparent paradox, insight into the probable mechanisms responsible for these observations was provided by establishing that UVR exposure of skin results in a striking and dose-dependent blockade of the efferent lymphatic vessels in all peripheral lymph nodes. Therefore, the afferent phases of immune responses can apparently take place normally in UVR exposed animals when antigen is applied to normal skin. The final effector responses, however, appear to be inhibited in the UVR-exposed animals by an apparent block of effector cell mobility. This contrasts with findings in the normal animals. Following contact sensitization, normal animals were also found to simultaneously contain both antigen specific suppressor T cells and lymph node effector cells. However, these normal animals were fully capable of mobilizing their effector cells into the systemic circulation, thereby allowing a localization of these cells to peripheral sites of antigen challenge. Our results suggest that UVR is probably not a significant inducer of suppressor T-cell activity to topically applied antigens. Rather, UVR exposure appears to modify the normal relationship which exists between effector and regulatory immune responses in vivo. It does so by either causing a direct reduction in the skin's APC function, a situation which results in an absence of effector cell generation to antigens applied to UVR-exposed skin sites, inhibiting the capacity of effector cells to gain access to skin sites of antigen challenge or by sequestering the lymphocytes with effector cell potential into the draining peripheral lymph nodes. Each of these situations result in a similar effect on the UVR-exposed host, that being a reduced capacity to elicit a CH response. We hypothesize that altered DTH responses, altered alloresponses, and altered graft-versus-host responses, all of which have been observed in UVR exposed animals, may result from similar mechanisms.